伟思医疗
(688580)
| 流通市值：48.81亿 | | | 总市值：48.81亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 210,453,384.34 | 95,912,701.63 | 400,058,923.31 | 291,757,867.37 |
| 营业收入 | 210,453,384.34 | 95,912,701.63 | 400,058,923.31 | 291,757,867.37 |
| 二、营业总成本 | 149,767,936.06 | 66,399,984.17 | 324,845,883.81 | 231,830,532.26 |
| 营业成本 | 71,365,174.28 | 31,984,614.54 | 138,226,444.43 | 84,368,036.05 |
| 税金及附加 | 2,973,485.55 | 1,411,588.66 | 5,531,255.12 | 3,972,320.64 |
| 销售费用 | 37,021,094.59 | 14,856,454.13 | 94,371,066.87 | 78,091,594.75 |
| 管理费用 | 19,829,588.28 | 9,530,691.39 | 44,548,847.18 | 33,635,402.69 |
| 研发费用 | 20,483,371.22 | 9,664,611.61 | 50,613,388.74 | 39,929,327.9 |
| 财务费用 | -1,904,777.86 | -1,047,976.16 | -8,445,118.53 | -8,166,149.77 |
| 其中:利息费用 | 701,883.15 | 351,255.24 | 1,308,733.32 | 965,574.45 |
| 其中:利息收入 | 2,615,347.78 | 1,402,873.76 | 9,772,871.34 | 9,146,676.08 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 2,419,469.21 | - |
| 加:投资收益 | 6,593,169.16 | 3,126,773.51 | 11,336,994.51 | 8,238,504.93 |
| 资产处置收益 | -864.63 | -864.63 | 3,909.66 | 434.96 |
| 资产减值损失(新) | - | - | -29,234.54 | - |
| 信用减值损失(新) | -180,911.06 | -84,188.61 | -1,276,267.87 | -133,334.87 |
| 其他收益 | 9,295,818.99 | 4,487,673.76 | 23,835,345.51 | 16,327,300.68 |
| 四、营业利润 | 76,392,660.74 | 37,042,111.49 | 111,503,255.98 | 84,360,240.81 |
| 加:营业外收入 | 155,019.38 | 4,560.1 | 1,846,339.35 | 143,811.99 |
| 减:营业外支出 | 11,598.68 | - | 70,832.72 | 28,529.64 |
| 五、利润总额 | 76,536,081.44 | 37,046,671.59 | 113,278,762.61 | 84,475,523.16 |
| 减:所得税费用 | 7,211,838.93 | 3,826,596.54 | 11,309,532.07 | 6,309,246.81 |
| 六、净利润 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 |
| 扣除非经常损益后的净利润 | 63,571,292.43 | 30,538,332.03 | 83,115,416.15 | 68,144,971.2 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.72 | 0.35 | 1.07 | 0.82 |
| (二)稀释每股收益 | 0.72 | 0.35 | 1.07 | 0.82 |
| 九、综合收益总额 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 |
| 归属于母公司股东的综合收益总额 | 69,324,242.51 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-25 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |